Hartmuth Nowak Selected Research

Aquaporin 5

1/2021	Corrigendum: The Aquaporin 5 -1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients.
1/2020	Major Adverse Kidney Events Are Associated with the Aquaporin 5 -1364A/C Promoter Polymorphism in Sepsis: A Prospective Validation Study.
12/2019	DNA methylation of a NF-κB binding site in the aquaporin 5 promoter impacts on mortality in sepsis.
1/2019	The Aquaporin 5 -1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients.
1/2018	The aquaporin 5 -1364A/C promoter polymorphism impacts on resolution of acute kidney injury in pneumonia evoked ARDS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hartmuth Nowak Research Topics

Disease

7	Sepsis (Septicemia) 07/2022 - 01/2017
5	Inflammation (Inflammations) 07/2022 - 01/2018
3	Cytomegalovirus Infections (Inclusion Disease) 12/2021 - 01/2019
3	Infections 12/2021 - 01/2019
2	Critical Illness (Critically Ill) 07/2022 - 12/2019
2	Hemorrhage 07/2022 - 07/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2018
2	Pneumonia (Pneumonitis) 01/2018 - 05/2017
1	COVID-19 07/2022
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Emergence Delirium 01/2022
1	Delirium 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Neuroblastoma 01/2022
1	Pain (Aches) 12/2020
1	Postoperative Pain 12/2020
1	Endotoxemia 10/2020
1	Airway Obstruction (Choking) 12/2019
1	Cerebral Hemorrhage 05/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017

Drug/Important Bio-Agent (IBA)

5	Aquaporin 5IBA 01/2021 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 12/2020 - 10/2020
1	Thrombin FDA Link 07/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2022
1	AnticoagulantsIBA 07/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2022
1	Heparin (Liquaemin)FDA LinkGeneric 07/2022
1	argatroban (MPQA)FDA Link 07/2022
1	ButyrylcholinesteraseIBA 01/2022
1	Cholinesterases (Cholinesterase)IBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	AcetylcholinesteraseIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	NucleotidesIBA 01/2020
1	CytosineIBA 12/2019
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	Albuterol (Salbutamol)FDA LinkGeneric 12/2019
1	N(4)-oleylcytosine arabinosideIBA 07/2018
1	Prothrombin (Factor II)IBA 07/2018
1	Moxifloxacin (Avelox)FDA Link 01/2017

Therapy/Procedure

3	Kidney Transplantation 12/2021 - 01/2019
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 12/2020
1	Analgesia 12/2020
1	Transplantation 01/2020
1	Artificial Respiration (Mechanical Ventilation) 12/2019
1	Mechanical Ventilators (Ventilator) 12/2019
1	Organ Transplantation 01/2019
1	Therapeutics 05/2017